UV SUPPORT- benzophenon-3, ethylhxyl salicyclate, homosalate, octocrylene, butyl methoxydibenzoyl methae, titanium dioxide, hydroxystearyl alcohol cream

UV Support by

Drug Labeling and Warnings

UV Support by is a Otc medication manufactured, distributed, or labeled by Novamed Healthcare Private Limited. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Instructions for Use

For best results and full protection apply UV-support to all exposed skin 15 minutes before sun exposure. Reapply UV-support after every two hours or as per need.

Indications and Usage

• Protects against harmful UVA/UVB rays
• Protects from sun burn
• Reduces premature aging and wrinkling
• Prevents dry & rough skin
• Fills uneven skin surface
• Water and sweat resistant

Inactive Ingredients

• Acrylamide/Sodium Acryloyldimethyltaurate Copolymer
• Caprylic/Capric Triglyceride
• Caprylyl/Capryl Glucoside
• Cetostearyl alcohol
• Cetyl alcohol
• Cyclomethicone
• EDTA
• Ethylene glycol distearate
• Glycerin
• Sodium benzoate
• Sodium lauryl sulphate
• Stearic acid
• Triethanolamine
• Water

Active Ingredients

• Benzophenon
• Butyl methoxydibenzoyl methane
• Ethylhexyl salicylate
• Homosalate
• Hydroxystearyl Alcohol
• Octocrylene
• Titanium dioxide

Keep out of the reach of Children

Keep out of the reach of Children

Purpose

Active Ingredient Purpose

Benzophenon Sunscreen (UV-A +UV-B protection)
Butyl methoxydibenzoyl methane Sunscreen (UV-A protection)
Ethylhexyl salicylate Sunscreen (UV-B protection)
Homosalate Sunscreen (UV-B protection)
Hydroxystearyl Alcohol Emulsifier
Octocrylene Sunscreen (UV-A +UV-B protection)
Titanium dioxide Opacifier + Sunscreen (UV-B protection)

Warnings

• In case of allergic reaction stop the use immediately & consult your doctor.
• Avoid contact with eyes.
• For external use only.
• Keep out of the reach of children

Dosage and Administration

UV-support should be used year-round before going outside.

Apply UV-support to all exposed skin 15 minutes before sun exposure.

Reapply UV-support after every two hours or as per need.

UV Support

INGREDIENTS AND APPEARANCE

UV SUPPORT 
benzophenon-3, ethylhxyl salicyclate, homosalate, octocrylene, butyl methoxydibenzoyl methae, titanium dioxide, hydroxystearyl alcohol cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 84859-115
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP)	TITANIUM DIOXIDE	0.75 g  in 30 g
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM)	OCTOCRYLENE	1.2 g  in 30 g
HYDROXYSTEARYL ALCOHOL (UNII: UN9IN5VLYE) (HYDROXYSTEARYL ALCOHOL - UNII:UN9IN5VLYE)	HYDROXYSTEARYL ALCOHOL	0.6 g  in 30 g
BENZOPHENONE (UNII: 701M4TTV9O) (BENZOPHENONE - UNII:701M4TTV9O)	BENZOPHENONE	1.2 g  in 30 g
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S)	HOMOSALATE	3 g  in 30 g
BUTYL METHOXYDIBENZOYLMETHANE (UNII: G63QQF2NOX) (BUTYL METHOXYDIBENZOYLMETHANE - UNII:G63QQF2NOX)	BUTYL METHOXYDIBENZOYLMETHANE	0.9 g  in 30 g
ETHYLHEXYL SALICYLATE (UNII: 4X49Y0596W) (ETHYLHEXYL SALICYLATE - UNII:4X49Y0596W)	ETHYLHEXYL SALICYLATE	1.5 g  in 30 g

Inactive Ingredients
Ingredient Name	Strength
ACRYLAMIDE/SODIUM ACRYLOYLDIMETHYLTAURATE COPOLYMER (120000 MPA.S AT 1%) (UNII: 5F4963KLHS)	0.3 g  in 30 g
TRIETHANOLAMINE (UNII: 9O3K93S3TK)	0.18 g  in 30 g
SODIUM BENZOATE (UNII: OJ245FE5EU)	0.09 g  in 30 g
GLYCERIN (UNII: PDC6A3C0OX)	0.9 g  in 30 g
CAPRYLIC/CAPRIC TRIGLYCERIDE (UNII: C9H2L21V7U)	0.75 g  in 30 g
CETYL ALCOHOL (UNII: 936JST6JCN)	0.9 g  in 30 g
CYCLOMETHICONE (UNII: NMQ347994Z)	0.9 g  in 30 g
STEARIC ACID (UNII: 4ELV7Z65AP)	2.4 g  in 30 g
EDTA (UNII: 9G34HU7RV0)	0.03 g  in 30 g
CAPRYLYL/CAPRYL GLUCOSIDE (UNII: E00JL9G9K0)	0.15 g  in 30 g
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)	0.9 g  in 30 g
WATER (UNII: 059QF0KO0R)	11.667 mL  in 30 g
DIETHYLENE GLYCOL DISTEARATE (UNII: 617Q4OD69O)	0.9 g  in 30 g
SODIUM LAURYL SULFATE (UNII: 368GB5141J)	0.15 g  in 30 g

Product Characteristics
Color	white	Score
Shape		Size
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 84859-115-01	1 in 1 BOX	02/26/2025
1	NDC: 84859-115-30	30 g in 1 TUBE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	02/26/2025

Labeler - Novamed Healthcare Private Limited (645814547)

Registrant - Novamed Healthcare Private Limited (645814547)

Establishment
Name	Address	ID/FEI	Business Operations
Novamed Healthcare Private Limited		645814547	manufacture(84859-115) , label(84859-115) , pack(84859-115)